RE:RE:RE:Milestone paymentsI think Howie's first mistake was teaming up with a two-bit company like Rodan and Fields, allowing them to string us along while they did absolutely nothing with 1067. That hurt our credibility a lot.
Allergen is a whole different ballgame, as they wouldn't have bothered with us if they didn't see some potential there. But they are like a massive iceberg, slow to get going but once on the move, hard to stop. They will take their sweet time coming up with a 1067 product, as they look long term. Frustrating for SBM and their shareholders for sure, but I wouldn't write them off so quick.